Anti-TNF-α agent infliximab and splenectomy are protective against renal ischemia-reperfusion injury

Transplantation

Volumn 100, Issue 8, 2016, Pages 1675-1682

  Nagata, Yudai ^a   Fujimoto, Mitsuaki ^a   Nakamura, Kimihiko ^a   Isoyama, Naohito ^a   Matsumura, Masafumi ^a   Fujikawa, Koki ^a   Uchiyama, Koichi ^a   Takaki, Eiichi ^a   Takii, Ryosuke ^a   Nakai, Akira ^a   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYTOKINE; HEAT SHOCK PROTEIN 70; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; MACROPHAGE; MALE; MONOCYTE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SPLENECTOMY; UREA NITROGEN BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPARATIVE STUDY; DELAYED GRAFT FUNCTION; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; KIDNEY TRANSPLANTATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; BLOOD UREA NITROGEN; CREATININE; DELAYED GRAFT FUNCTION; DISEASE MODELS, ANIMAL; HSP70 HEAT-SHOCK PROTEINS; INFLIXIMAB; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; MONOCYTES; RATS, WISTAR; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPLENECTOMY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84966264833     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001222     Document Type: Article

References (32)

1. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;14: 2199-2210.
2. Requião-Moura LR, Durão Mde S, Tonato EJ, et al. Effects of ischemia and reperfusion injury on long-term graft function. Transplant Proc. 2011;43:70-73.
3. Cooper JE, Wiseman AC. Acute kidney injury in kidney transplantation. Curr Opin Nephrol Hypertens. 2013;22:698-703.
4. Daha MR, van Kooten C. Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant. 2000;15(Suppl 6):41-43.
5. WajantH, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45-65.
6. Yang JR, Yao FH, Zhang JG, et al. Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway. Am J Physiol Renal Physiol. 2014;306:F75-F84.
7. Ranganathan P, Jayakumar C, Ramesh G. Proximal tubule-specific overexpression of netrin-1 suppresses acute kidney injury-induced interstitial fibrosis and glomerulosclerosis through suppression of IL-6/STAT3 signaling. Am J Physiol Renal Physiol. 2013;304:F1054-F1065.
8. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant. 2000;15:1562-1574.
9. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009;130:41-50.
10. Zhang PL, Lun M, Schworer CM, et al. Heat shock protein expression is highly sensitive to ischemia-reperfusion injury in rat kidneys. Ann Clin Lab Sci. 2008;38:57-64.
11. Hiroyoshi T, Tsuchida M, Uchiyama K, et al. Splenectomy protects the kidneys against ischemic reperfusion injury in the rat. Transpl Immunol. 2012; 27:8-11.
12. Wystrychowski W, Filipczyk L, Cierpka L, et al. Splenectomy attenuates the course of kidney ischemia-reperfusion injury in rats. Transplant Proc. 2014;46:2558-2561.
13. Tasdemir C, Tasdemir S, Vardi N, et al. Protective effect of infliximab on ischemia/reperfusion-induced damage in rat kidney. Ren Fail. 2012;34: 1144-1149.
14. KellumJA, Lameire N, KDIGO AKIGuidelineWork Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.
15. Liang Y, Li Z, Mo N, et al. Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and antiapoptotic actions in rats. Biol Pharm Bull. 2014;37:1599-1605.
16. Guo Q, Du X, Zhao Y, et al. Ischemic postconditioning prevents renal ischemia reperfusion injury through the induction of heat shock proteins in rats. Mol Med Rep. 2014;10:2875-2881.
17. Dong X, Swaminathan S, Bachman LA, et al. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007;71:619-628.
18. Sugita S, Kawazoe Y, Imai A, et al. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease. Arthritis Res Ther. 2012;14:R99.
19. Jo SK, Sung SA, Cho WY, et al. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant. 2006;21: 1231-1239.
20. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612-616.
21. Okuaki Y, Miyazaki H, Zeniya M, et al. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver. 1996;16:188-194.
22. Jiang H, Meng F, Li W, et al. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery. 2007;141:32-40.
23. Patel NS, Chatterjee PK, Di Paola R, et al. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther. 2005;312:1170-1178.
24. Furuichi K, Wada T, Iwata Y, et al. CCR2 signaling contributes to ischemiareperfusion injury in kidney. J Am Soc Nephrol. 2003;14:2503-2515.
25. Amanzada A, Moriconi F, Mansuroglu T, et al. Induction of chemokines and cytokines before neutrophils and macrophage recruitment in different regions of rat liver after TAA administration. Lab Invest. 2014;94:235-247.
26. Macklin PS, Morris PJ, Knight SR. A systematic review of the use of rituximab for desensitization in renal transplantation. Transplantation. 2014;98: 794-805.
27. Mahmoud MF, El Shazly SM, Barakat W. Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:465-471.
28. Pergel A, Kanter M, Yucel AF, et al. Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury. Toxicol Ind Health. 2012;28:923-932.
29. Guven C, Borcek AO, Cemil B, et al. Neuroprotective effects of infliximab in experimental spinal cord ischemic injury. J Clin Neurosci. 2010;17: 1563-1567.
30. Di Paola R, Genovese T, Impellizzeri D, et al. The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: a comparison with infliximab treatment. Eur J Pharmacol. 2013;700:134-146.
31. Kelsall J, Rogers P, Galindo G, et al. Safety of infliximab treatment in patients with rheumatoid arthritis in a real-world clinical setting: description and evaluation of infusion reactions. J Rheumatol. 2012;39:1539-1545.
32. Sprakes MB, Ford AC, Warren L, et al. Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience. J Crohns Colitis. 2012;6:143-153.